Likewise, TNFRSF1A expression of gliomas carrying 1p/19q codeletion or IDH mutation was lower than the corresponding glioma samples (Figures 4Q–V; Supplementary Tables 1–3). The gene discussed is IDH1; the disease is central nervous system cancer.